BamSEC and AlphaSense Join Forces
Learn More

TransCode Therapeutics Inc. – Indentures

NASDAQ: RNAZ    
Share price (6/26/26): $4.97    
Market cap (6/26/26): $4.723 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.22
from 10-K 38 pages Indenture or similar
12/34/56
EX-4.2
from 8-K 15 pages Registration Rights Agreement
12/34/56
EX-4.2
from DEFA14A 15 pages Registration Rights Agreement
12/34/56
EX-4.1
from 8-K 22 pages TransCode Therapeutics, Inc. Convertible Promissory Note
12/34/56
EX-4.1
from DEFA14A 22 pages TransCode Therapeutics, Inc. Convertible Promissory Note
12/34/56
EX-4.5
from S-3 34 pages TransCode Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.4
from S-3 34 pages TransCode Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.1
from DEFA14A 20 pages Registration Rights Agreement
12/34/56
EX-4.1
from 8-K 20 pages Registration Rights Agreement
12/34/56
EX-4.2
from 8-K 22 pages Form of Placement Agent Warrant Agreement
12/34/56
EX-4.1
from 8-K 19 pages Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.3
from 8-K 18 pages Series D Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 21 pages Series C Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 16 pages Prefunded Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 23 pages Form of Representative’s Warrant Agreement
12/34/56
EX-4.3
from S-1/A 20 pages Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.4
from S-1/A 20 pages Placement Agent Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.3
from S-1/A 20 pages Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.2
from S-1/A 19 pages Pre-Funded Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 19 pages Placement Agent Common Stock Purchase Warrant TransCode Therapeutics, Inc
12/34/56